Diminished basal phosphorylation level of phospholamban in the postinfarction remodeled rat ventricle -: Role of β-adrenergic pathway, Gi protein, phosphodiesterase, and phosphatases

被引:88
作者
Huang, BY
Wang, S
Qin, DY
Boutjdir, M
El-Sherif, N
机构
[1] SUNY Hlth Sci Ctr, Div Cardiol, Dept Med, Brooklyn, NY 11203 USA
[2] Vet Affairs Med Ctr, Brooklyn, NY USA
[3] NIA, Cardiovasc Sci Lab, Gerontol Res Ctr, NIH, Baltimore, MD 21224 USA
关键词
phospholamban; phosphatase; postmyocardial infarction; sarcoplasmic reticulum;
D O I
10.1161/01.RES.85.9.848
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Three weeks after myocardial infarction (MI) in the rat, remodeled hypertrophy of noninfarcted myocardium is at its maximum and the heart is in a compensated stage with no evidence of heart failure. Our hemodynamic measurements at this stage showed a slight but insignificant decrease of +dP/dt but a significantly higher left ventricular end-diastolic pressure. To investigate the basis of the diastolic dysfunction, we explored possible defects in the beta-adrenergic receptor-G(s/i) protein-adenylyl cyclase-cAMP-protein kinase A-phosphatase pathway, as well as molecular or functional alterations of sarcoplasmic reticulum Ca2+-ATPase and phospholamban (PLB). We found no significant difference in both mRNA and protein levels of sarcoplasmic reticulum Ca2+-ATPase and PLB in post-MI left ventricle compared with control. However, the basal levels of both the protein kinase A-phosphorylated site (Ser16) of PLB (p16-PLB) and the calcium/calmodulin-dependent protein kinase-phosphorylated site (Thr17) of PLB (p17-PLB) were decreased by 76% and 51% in post-MI myocytes (P < 0.05), respectively. No change was found in the P-adrenoceptor density, G(s alpha) protein level, or adenylyl cyclase activity. Inhibition of phosphodiesterase and G(i) protein by Ro-20-1724 and pertussis toxin respectively, did not correct the decreased p16-PLB or p17-PLB levels. Stimulation of beta-adrenoceptor or adenylyl cyclase increased both p16-PLB and p17-PLB in post-MI myocytes to the same levels as in sham myocytes, suggesting that decreased p16-PLB and p17-PLB in post-MI myocytes is not due to a decrease in the generation of p16-PLB or p17-PLB. We found that type I phosphatase activity was increased by 32% (P < 0.05) with no change in phosphatase 2A activity. Okadaic acid, a protein phosphatase inhibitor, significantly increased p16-PLB and p17-PLB levels in post-MI myocytes and partially corrected the prolonged relaxation of the [Ca2+](i) transient. In summary, prolonged relaxation of post-MI remodeled myocardium could be explained, in part, by altered basal levels of p16-PLB and p17-PLB caused by increased protein phosphatase 1 activity.
引用
收藏
页码:848 / 855
页数:8
相关论文
共 56 条
[31]   Transgenic approaches to define the functional role of dual site phospholamban phosphorylation [J].
Luo, WS ;
Chu, GX ;
Sato, Y ;
Zhou, ZP ;
Kadambi, VJ ;
Kranias, EG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (08) :4734-4739
[32]   TARGETED ABLATION OF THE PHOSPHOLAMBAN GENE IS ASSOCIATED WITH MARKEDLY ENHANCED MYOCARDIAL-CONTRACTILITY AND LOSS OF BETA-AGONIST STIMULATION [J].
LUO, WS ;
GRUPP, IL ;
HARRER, J ;
PONNIAH, S ;
GRUPP, G ;
DUFFY, JJ ;
DOETSCHMAN, T ;
KRANIAS, EG .
CIRCULATION RESEARCH, 1994, 75 (03) :401-409
[33]   IDENTIFICATION OF THE MAJOR PROTEIN PHOSPHATASES IN MAMMALIAN CARDIAC-MUSCLE WHICH DEPHOSPHORYLATE PHOSPHOLAMBAN [J].
MACDOUGALL, LK ;
JONES, LR ;
COHEN, P .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1991, 196 (03) :725-734
[34]   ALTERED SARCOPLASMIC-RETICULUM CA-2+-ATPASE GENE-EXPRESSION IN THE HUMAN VENTRICLE DURING END-STAGE HEART-FAILURE [J].
MERCADIER, JJ ;
LOMPRE, AM ;
DUC, P ;
BOHELER, KR ;
FRAYSSE, JB ;
WISNEWSKY, C ;
ALLEN, PD ;
KOMAJDA, M ;
SCHWARTZ, K .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (01) :305-309
[35]  
MORGAN JP, 1991, NEW ENGL J MED, V325, P625
[36]   CA2+-TRANSPORTING ATPASE, PHOSPHOLAMBAN, AND CALSEQUESTRIN LEVELS IN NONFAILING AND FAILING HUMAN MYOCARDIUM [J].
MOVSESIAN, MA ;
KARIMI, M ;
GREEN, K ;
JONES, LR .
CIRCULATION, 1994, 90 (02) :653-657
[37]   Unchanged protein expression of sarcoplasmic reticulum Ca2+-ATPase, phospholamban, and calsequestrin in terminally failing human myocardium [J].
Münch, G ;
Bölck, B ;
Hoischen, S ;
Brixius, K ;
Bloch, W ;
Reuter, H ;
Schwinger, RHG .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1998, 76 (06) :434-441
[38]   LIGAND - A VERSATILE COMPUTERIZED APPROACH FOR CHARACTERIZATION OF LIGAND-BINDING SYSTEMS [J].
MUNSON, PJ ;
RODBARD, D .
ANALYTICAL BIOCHEMISTRY, 1980, 107 (01) :220-239
[39]   EVIDENCE FOR ISOPROTERENOL-INDUCED PHOSPHORYLATION OF PHOSPHATASE INHIBITOR-1 IN THE INTACT HEART [J].
NEUMANN, J ;
GUPTA, RC ;
SCHMITZ, W ;
SCHOLZ, H ;
NAIRN, AC ;
WATANABE, AM .
CIRCULATION RESEARCH, 1991, 69 (06) :1450-1457
[40]   Increased expression of cardiac phosphatases in patients with end-stage heart failure [J].
Neumann, J ;
Eschenhagen, T ;
Jones, LR ;
Linck, B ;
Schmitz, W ;
Scholz, H ;
Zimmermann, N .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1997, 29 (01) :265-272